key: cord-0846459-k74wm46p
authors: Porfidia, Angelo; Talerico, Rosa; Mosoni, Carolina; Porceddu, Enrica; Pola, Roberto
title: CT Pulmonary Angiography for the Diagnosis of Pulmonary Embolism in Patients with COVID-19: When, Why, and for Who?
date: 2021-03-23
journal: Radiology
DOI: 10.1148/radiol.2021210400
sha: 06b7ea1e92afef0dcff90aa7761ddf067a809d46
doc_id: 846459
cord_uid: k74wm46p

nan

The meta-analysis published by Suh and coll. in a recent issue of Radiology (1) is just the last of a series of reports that support the concept that pulmonary embolism (PE) is a very frequent complication in patients hospitalized for coronavirus disease-19 (COVID-19). However, this awareness does not correspond to an adequate diagnostic effort towards PE. Indeed, clear indications on the appropriate use of computed tomography pulmonary angiography (CTPA) for the diagnosis of PE in COVID-19 patients are still lacking. If we look at the single studies taken into account by the many meta-analyses published in the last year (1-5), we will see that the proportion of patients who underwent CTPA varied from 2.1% to 100%. In many studies, this information was not even provided. In others, the proportion of patients who underwent CTPA was unknown. It is obvious that this has a strong influence on the end-point of these studies, i.e. the incidence of PE, which might be underestimated. We believe that it would be important to understand why some COVID-19 patients underwent CTPA in these studies, while others did not. Were they different, in terms of demographical, clinical, and/or laboratory characteristics, from those who did not undergo CTPA? More in general, we believe that it would be important to determine which proportion of patients in these studies had a theoretical indication to undergo CTPA, based on the probability scoring systems and the rule-out algorithms that are commonly used for diagnosing PE. Until the decision of ordering CTPA will be left to the discretion of the individual physician, it will be impossible to establish the precise incidence of PE in patients hospitalized for COVID-19, as well its actual impact on prognosis. Our meta-analysis rapidly provided information on the pooled incidence and range of PE in early studies on COVID-19 patients, and also discussed how the incidence was unevenly distributed according to several important factors such as intensive care unit treatment, deep vein thrombosis, and the proportion of patients who underwent CTPA. We believe that the results of our analysis will help authors understand variation in the reported incidence of PE in the literature on COVID-19.

Furthermore, we established a basis for applying the pre-existing rule-out algorithm based on Ddimer (which the authors emphasized) to COVID-19 by soliciting individual patient data from 11 studies. Therefore, the implications of this study go far beyond simply listing a series of reports on PE in COVID-19.

Pulmonary embolism and deep vein thrombosis in COVID-19: A systematic review and meta-analysis

Prevalence of venous thromboembolic events in novel coronavirus disease-2019 patients: Systematic review and meta-analysis

Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysis

Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis

Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis

Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis

The European Society for Cardiology. ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic

Pulmonary thromboembolic disease in COVID-19 patients on CT pulmonary angiography -Prevalence, pattern of disease and relationship to D-dimer

Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations

The indeterminate CT pulmonary angiogram: imaging characteristics and patient clinical outcome